MCL1
Showing 676 - 694 of 694
After Pandemic Influenza A Vaccine in Onco- Hematologic Patients
Completed
- Lymphoma
- +2 more
- Reassortant vaccine virus NYMC X-179A (New York Medical College, New York) derived form the A/california/7/2009 (H1N1) virus
-
Milan, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Jul 29, 2011
Cutaneous Leishmaniasis Trial in Floridablanca (controlled nitric oxide releasing patch, meglumine antimoniate)
Terminated
- Cutaneous Leishmaniasis
- controlled nitric oxide releasing patch
- meglumine antimoniate
-
Floridablanca, Santander, ColombiaFundaciĆ³n Cardiovascular de Colombia
Nov 23, 2010
Acute Myelogenous Leukemia Trial in Seoul (Cytarabine plus Daunorubicin [Arm II (AD regimen)])
Unknown status
- Acute Myelogenous Leukemia
- Cytarabine plus Daunorubicin [Arm II (AD regimen)]
-
Seoul, Songpa-gu, Korea, Republic ofAsan Medical Center
Jun 16, 2010
Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma. Trial (MDX-1411)
Withdrawn
- Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma.
- MDX-1411
- (no location specified)
Apr 21, 2010
Acute Myeloid Leukemia Trial in Seoul (HDAC chemo, Autologous HCT)
Unknown status
- Acute Myeloid Leukemia
- HDAC chemotherapy
- Autologous HCT
-
Seoul, Asanbyeongwon-gil, songpa-gu, Korea, Republic ofAsan Medical Center
Jun 17, 2010
Skin Aging Trial in Karlsruhe (Fractional carbon dioxide laser treatment, Fractional Er:YAG laser treatment)
Completed
- Skin Aging
- Fractional carbon dioxide laser treatment
- Fractional Er:YAG laser treatment
-
Karlsruhe, GermanyLaserklinik Karlsruhe
Oct 13, 2009
Peri-orbital Rhytides Trial in Karlsruhe (Fractional carbon dioxide laser treatment, Fractional erbium:YAG laser treatment)
Completed
- Peri-orbital Rhytides
- Fractional carbon dioxide laser treatment
- Fractional erbium:YAG laser treatment
-
Karlsruhe, GermanyLaserklinik Karlsruhe
Oct 13, 2009
Mantle-Cell Lymphoma Trial in Heidelberg (Immunochemo, High-dose BEAM plus autologous SCT, HLA-identical allogenic SCT)
Unknown status
- Mantle-Cell Lymphoma
- Immunochemotherapy
- +2 more
-
Heidelberg, GermanyUniversity Hospital
Jul 24, 2009
Pain Trial in Salt Lake City (Capsaicin Topical Liquid)
Completed
- Pain
- Capsaicin Topical Liquid
-
Salt Lake City, UtahLifetree Clinical Research
Jun 2, 2009
Rheumatoid Arthritis Trial in Hong Kong (rituximab)
Completed
- Rheumatoid Arthritis
-
Hong Kong, ChinaDepartment of Medicine and Therapeutics
May 7, 2008
Drug Resistance in Tumor Biopsies From Previously Untreated
Completed
- Non-Hodgkin Lymphoma
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Pain Trial (Capsaicin Dermal Liquid)
Completed
- Pain
- Capsaicin Dermal Liquid
- (no location specified)
Mar 4, 2008
HIV, AIDS Trial in Bergamo (STI, stable HAART)
Completed
- HIV Infections
- AIDS
- STI
- stable HAART
-
Bergamo, BG, ItalyOspedali Riuniti
Apr 24, 2008
Multiple Organ Dysfunction Syndrome Trial in Spain (6-methyl-prednisolone)
Unknown status
- Multiple Organ Dysfunction Syndrome
-
Alcala de Henares, Madrid, Spain
- +5 more
May 12, 2008
Lymphoma, Mantle-Cell Trial in Vienna (bortezomib, rituximab, dexamethasone)
Unknown status
- Lymphoma, Mantle-Cell
- bortezomib
- +3 more
-
Vienna, AustriaMedical University Vienna, Dept. of Medicine I, Clinical Divisio
Oct 17, 2006
HIV Infection Trial in Bergamo (STI (structured Treatment Interruption))
Completed
- HIV Infection
- STI (structured Treatment Interruption)
-
Bergamo, ItalyAntiviral Therapy Unit, Ospedali Riuniti
Jul 21, 2006
Mantle Cell Lymphoma Trial in Chicago, New York, Philadelphia (Iodine-131 Anti-B1 Antibody, Cyclophosphamide, Doxorubicin,
Completed
- Mantle Cell Lymphoma
- Iodine-131 Anti-B1 Antibody
- Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP)
-
Chicago, Illinois
- +2 more
Jun 23, 2005